Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.

Autor: Tauchi, Tetsuzo1 (AUTHOR) tauchi144@gmail.com, Moriya, Shota2 (AUTHOR), Okabe, Seiichi3 (AUTHOR), Kazama, Hiromi2 (AUTHOR), Miyazawa, Keisuke2 (AUTHOR), Takano, Naoharu2 (AUTHOR) tauchi144@gmail.com
Zdroj: PLoS ONE. 7/25/2024, Vol. 19 Issue 7, p1-19. 19p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje